Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Breast Dis. 2010 Jan 1;31(1):7–18. doi: 10.3233/BD-2009-0290

Figure 4.

Figure 4

Observed and predicted MX-1 xenograft tumor volumes when treated at 2 capecitabine doses (1.5 mmol/kg/day and 2.25 mmol/kg/day). Capecitabine is administered on the conventional 14-7 schedule. Mean tumor volumes shown for 10 mice per treatment group.